Home   Categories   Grid

Subscribe Now

AstraZeneca completes $39bn acquisition of Alexion Pharmaceuticals

AstraZeneca completes $39bn acquisition of Alexion Pharmaceuticals

AstraZeneca completes $39bn acquisition of Alexion Pharmaceuticals

21 July 2021

It brings the company greater immunology and rare disease expertise.


Award for Cambridge researchers who showed plasma viscosity can predict progression of Covid-19

Award for Cambridge researchers who showed plasma viscosity can predict progression of Covid-19

Award for Cambridge researchers who showed plasma viscosity can predict progression of Covid-19

16 July 2021

Daniel Gleghorn and colleagues at Cambridge University Hospitals won the award from Benson Viscometers.


$45m upfront fee for Bicycle Therapeutics under deal with Ionis Pharmaceuticals

$45m upfront fee for Bicycle Therapeutics under deal with Ionis Pharmaceuticals

$45m upfront fee for Bicycle Therapeutics under deal with Ionis Pharmaceuticals

13 July 2021

The Babraham Research Campus company will develop tissue-targeted oligonucleotide therapeutics.


Apollo Therapeutics’ $145m financing follows collaboration at University of Cambridge, Imperial College London and UCL

Apollo Therapeutics’ $145m financing follows collaboration at University of Cambridge, Imperial College London and UCL

Apollo Therapeutics’ $145m financing follows collaboration at University of Cambridge, Imperial College London and UCL

09 July 2021

The company was created to speed up the development of therapeutics.


Prof Wolf Reik steps down as director of Babraham Institute

Prof Wolf Reik steps down as director of Babraham Institute

Prof Wolf Reik steps down as director of Babraham Institute

09 July 2021

Dr Simon Cook is appointed interim director.


AstraZeneca’s $39bn acquisition of Alexion Pharmaceuticals clears European Commission review

AstraZeneca’s $39bn acquisition of Alexion Pharmaceuticals clears European Commission review

AstraZeneca’s $39bn acquisition of Alexion Pharmaceuticals clears European Commission review

06 July 2021

UK regulatory approval is still required for the deal to proceed.


Microbiotica to take precision live bacterial therapeutic in immuno-oncology into clinic in 2022

Microbiotica to take precision live bacterial therapeutic in immuno-oncology into clinic in 2022

Microbiotica to take precision live bacterial therapeutic in immuno-oncology into clinic in 2022

02 July 2021

It is designed to improve patient response to immune checkpoint inhibitor therapy.


Genmed to manage genomics laboratory service for Cambridge University Hospitals

Genmed to manage genomics laboratory service for Cambridge University Hospitals

Genmed to manage genomics laboratory service for Cambridge University Hospitals

01 July 2021

It has signed a four-year deal.


Equitable drug development to be discussed at Impact Women’s Network meeting in July

Equitable drug development to be discussed at Impact Women’s Network meeting in July

Equitable drug development to be discussed at Impact Women’s Network meeting in July

30 June 2021

A lightning talk will be delivered by Dilrini De Silva.


Congenica gets £2m to help tackle adverse drug reactions

Congenica gets £2m to help tackle adverse drug reactions

Congenica gets £2m to help tackle adverse drug reactions

25 June 2021

Nearly half of older people in the UK take five or more medicines

1

Cambridge scientists show targeting cellular response to Covid-19 is effective in the lab

Cambridge scientists show targeting cellular response to Covid-19 is effective in the lab

Cambridge scientists show targeting cellular response to Covid-19 is effective in the lab

23 June 2021

The new approach - if proved safe for humans - could significantly reduce symptoms and recovery times.

1

Queen’s Birthday Honours 2021: Eight AstraZeneca staff honoured for work during Covid-19 pandemic

Queen’s Birthday Honours 2021: Eight AstraZeneca staff honoured for work during Covid-19 pandemic

Queen’s Birthday Honours 2021: Eight AstraZeneca staff honoured for work during Covid-19 pandemic

11 June 2021

‘Many have worked around the clock in the past 12 months’ says the Cambridge-based company.


Cells with synthetic genomes reprogrammed at MRC LMB - and could create new drugs or biodegradable plastics

Cells with synthetic genomes reprogrammed at MRC LMB - and could create new drugs or biodegradable plastics

Cells with synthetic genomes reprogrammed at MRC LMB - and could create new drugs or biodegradable plastics

11 June 2021

It is a potentially revolutionary step forward in molecular biology.


AstraZeneca reveals trial results for breast cancer, lung cancer and leukaemia drugs and appoints CFO

AstraZeneca reveals trial results for breast cancer, lung cancer and leukaemia drugs and appoints CFO

AstraZeneca reveals trial results for breast cancer, lung cancer and leukaemia drugs and appoints CFO

10 June 2021

The company also has a new EU approval for Tagrisso.


Arecor Therapeutics to develop intravenous formulation of Par Sterile Products’ medicine

Arecor Therapeutics to develop intravenous formulation of Par Sterile Products’ medicine

Arecor Therapeutics to develop intravenous formulation of Par Sterile Products’ medicine

10 June 2021

It will use its Arestat platform.


Sphere Fluidics teams up with ClexBio for hydrogel kit that enables researchers to study cells for longer

Sphere Fluidics teams up with ClexBio for hydrogel kit that enables researchers to study cells for longer

Sphere Fluidics teams up with ClexBio for hydrogel kit that enables researchers to study cells for longer

09 June 2021

It can be used by those working on 3D cell cultures, organoids, single-cell analysis and other applications.


Avacta’s Covid-19 lateral flow test can be sold in UK after MHRA registration confirmed

Avacta’s Covid-19 lateral flow test can be sold in UK after MHRA registration confirmed

Avacta’s Covid-19 lateral flow test can be sold in UK after MHRA registration confirmed

09 June 2021

The company is now focusing on the commercial roll-out.


Lucida Medical earns CE mark for AI-powered prostate cancer detection software

Lucida Medical earns CE mark for AI-powered prostate cancer detection software

Lucida Medical earns CE mark for AI-powered prostate cancer detection software

04 June 2021

Its technology, Pi, which helps analyse MRI scans, is now eligible for use in the NHS.


Dreamt up over a pint at the Panton Arms: Cambridge chemists tell astonishing story of DNA sequencing after 1m euro prize

Dreamt up over a pint at the Panton Arms: Cambridge chemists tell astonishing story of DNA sequencing after 1m euro prize

Dreamt up over a pint at the Panton Arms: Cambridge chemists tell astonishing story of DNA sequencing after 1m euro prize

27 May 2021

Dr Shankar Balasubramanian and Dr David Klenerman also discuss the possibility of $100 genome sequencing.


Unveiled: 30-year vision for Cambridge Biomedical Campus

Unveiled: 30-year vision for Cambridge Biomedical Campus

Unveiled: 30-year vision for Cambridge Biomedical Campus

21 May 2021

Homes, shops, restaurants and green space will be integrated alongside hospitals and world-leading life science work.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More